Validation Data Gallery
|Positive WB detected in||Jurkat cells, mouse testis tissue, K-562 cells, HeLa cells, mouse thymus tissue|
|Positive IP detected in||mouse testis tissue|
|Positive IF detected in||HeLa cells|
|Western Blot (WB)||WB : 1:200-1:1000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:200-1:1000 for WB|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
10215-1-AP targets FANCG in WB, IP, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||FANCG fusion protein Ag0249|
|Full Name||Fanconi anemia, complementation group G|
|Calculated molecular weight||69 kDa|
|Observed molecular weight||65-68 kDa|
|GenBank accession number||BC000032|
|Gene ID (NCBI)||2189|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
FANCG, also named as XRCC9, is a vDNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. It's a candidate tumor suppressor gene. FANCA and FANCG are critical for the localization of the FANC core complex. FANCA and FANCG form a stable complex with a molecular weight of ∼500 kDa that is predicted to be a heterotetramer (PMID: 32002546).
Clin Transl Oncol
Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study.
Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma.